TW200721989A - Process for the ultra-soluble and full-absorbable pearl powder preparation - Google Patents

Process for the ultra-soluble and full-absorbable pearl powder preparation

Info

Publication number
TW200721989A
TW200721989A TW094143056A TW94143056A TW200721989A TW 200721989 A TW200721989 A TW 200721989A TW 094143056 A TW094143056 A TW 094143056A TW 94143056 A TW94143056 A TW 94143056A TW 200721989 A TW200721989 A TW 200721989A
Authority
TW
Taiwan
Prior art keywords
pearl powder
absorbable
soluble
full
ultra
Prior art date
Application number
TW094143056A
Other languages
Chinese (zh)
Other versions
TWI300336B (en
Inventor
Shui-So Lin
Original Assignee
Zih Mao Entpr Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zih Mao Entpr Co Ltd filed Critical Zih Mao Entpr Co Ltd
Priority to TW94143056A priority Critical patent/TWI300336B/en
Publication of TW200721989A publication Critical patent/TW200721989A/en
Application granted granted Critical
Publication of TWI300336B publication Critical patent/TWI300336B/en

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The process to prepare ultra-soluble and full-absorbable pearl powder includes detoxification, ball milling, producing via biotechnology and chemical engineering, and vacuum-freeze drying. The process can eliminate heavy metals, upgrade the solubility of pearl powder and preserve the active compounds, including the organic biocalcium, amino acids, peptides and minerals. The ultra-soluble and full-absorbable pearl powder can be applying into functional foods, cosmetics, drugs and beverages etc.
TW94143056A 2005-12-07 2005-12-07 Method for prepareation of the ultra-soluble and full-absorbable pearl powder TWI300336B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW94143056A TWI300336B (en) 2005-12-07 2005-12-07 Method for prepareation of the ultra-soluble and full-absorbable pearl powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW94143056A TWI300336B (en) 2005-12-07 2005-12-07 Method for prepareation of the ultra-soluble and full-absorbable pearl powder

Publications (2)

Publication Number Publication Date
TW200721989A true TW200721989A (en) 2007-06-16
TWI300336B TWI300336B (en) 2008-09-01

Family

ID=45069941

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94143056A TWI300336B (en) 2005-12-07 2005-12-07 Method for prepareation of the ultra-soluble and full-absorbable pearl powder

Country Status (1)

Country Link
TW (1) TWI300336B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111979285A (en) * 2020-08-27 2020-11-24 浙江长生鸟健康科技股份有限公司 Preparation method of pearl peptide chelated calcium

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111979285A (en) * 2020-08-27 2020-11-24 浙江长生鸟健康科技股份有限公司 Preparation method of pearl peptide chelated calcium

Also Published As

Publication number Publication date
TWI300336B (en) 2008-09-01

Similar Documents

Publication Publication Date Title
MX2011010673A (en) Nanoparticle formulations and uses therof.
ZA200803350B (en) Method of acting upon organism by targeted delivery of biologically active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
WO2008007151A3 (en) Processes for preparing pharmaceutical compositions
IL189008A (en) 1-naphthalenyl-3-azabicyclo[3.1.0]hexane derivatives, process for their preparation and pharmaceutical compositions comprising them
WO2007081974A3 (en) Viral hepatitis treatment
EP1928802B8 (en) Powder redispersible in water, process for production thereof and use thereof
WO2008013966A3 (en) Use of 8-quinolinol and its analogs to target cancer stem cells
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
WO2007059202A3 (en) Pyrazolyl urea derivatives useful in the treatment of cancer
WO2007059008A3 (en) N-substituted indenoisoquinolines and syntheses thereof
PH12013502192A1 (en) Antibodies against human angiopoietin 2
WO2008132224A3 (en) Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
GEP20115231B (en) 2-amino-7,8-dihydro-6h-pyrido [4,3-d] pyrimidin-5-ones
WO2008028117A3 (en) Glp-2 mimetibodies, polypeptides, compositions, methods and uses
WO2007075870A3 (en) Processes for taxane derivatives and intermediates useful therein
WO2006042661A3 (en) Oligopeptides and their use in cosmetics
EP2293808A4 (en) An synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
WO2006103672A3 (en) Spherically shaped substances
EP2303911A4 (en) An synthetic peptide containing bone forming peptide 2(bfp 2) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
EP1651651A4 (en) Nano-particles comprising cucurbituril derivatives, pharmaceutical composition containing the same, and process for the preparation thereof
WO2006081997A3 (en) Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostate hyperplasia, prostate carcinoma, and spinobulbar muscular atrophy
SI1707564T1 (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
WO2006081293A3 (en) Delivery of bio-available compounds with anhydrous topical preparations
WO2007075452A3 (en) Lyophilized compositions of a triazolopyrimidine compound
WO2006122777A3 (en) Use of 2,5-disubstituted thiazol-4-one derivatives in drugs